Disparate influence of pretreatment neutrophil-lymphocyte ratio and systemic immune-inflammation index on survival of EGFR-mutated against ALK/ROS1 rearranged metastatic non-small cell lung cancer — implications beyond the prognosis?
Nowotwory. Journal of Oncology · 26.02.2026 · 76 (1) · 16-25
DOI: 10.5603/njo.108410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nowotwory. Journal of Oncology, online erschienen am 26.02.2026. Verfasst von Rafał Suwiński und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Suwiński, R., Kysiak, M., Galwas, K., Idasiak, A., Oczko-Wojciechowska, M., Świerniak, A., & Wilk, A. (2026). Disparate influence of pretreatment neutrophil-lymphocyte ratio and systemic immune-inflammation index on survival of EGFR-mutated against ALK/ROS1 rearranged metastatic non-small cell lung cancer — implications beyond the prognosis?. Nowotwory. Journal of Oncology, 76(1), 16-25. https://doi.org/10.5603/njo.108410
Vancouver
Suwiński R, Kysiak M, Galwas K, Idasiak A, Oczko-Wojciechowska M, Świerniak A, et al. Disparate influence of pretreatment neutrophil-lymphocyte ratio and systemic immune-inflammation index on survival of EGFR-mutated against ALK/ROS1 rearranged metastatic non-small cell lung cancer — implications beyond the prognosis?. Nowotwory. Journal of Oncology. 2026;76(1):16-25. doi:10.5603/njo.108410
BibTeX
@article{Suwiski2026,
author = {Suwiński, Rafał and Kysiak, Marzena and Galwas, Katarzyna and Idasiak, Adam and Oczko-Wojciechowska, Małgorzata and Świerniak, Andrzej and Wilk, Agata},
title = {Disparate influence of pretreatment neutrophil-lymphocyte ratio and systemic immune-inflammation index on survival of EGFR-mutated against ALK/ROS1 rearranged metastatic non-small cell lung cancer — implications beyond the prognosis?},
journal = {Nowotwory. Journal of Oncology},
year = {2026},
volume = {76},
number = {1},
pages = {16--25},
doi = {10.5603/njo.108410}
}
EUVIMED